Telaprevir, peginterferon alfa-2a, and ribavirin for 28 days in chronic hepatitis C patients

被引：13
|
作者：
Zeuzem, Stefan [1 ]
机构：
[1] JW Goethe Univ Hosp, Dept Med 1, D-60590 Frankfurt, Germany
来源：
JOURNAL OF HEPATOLOGY | 2008年 / 49卷 / 02期
关键词：
D O I：
10.1016/j.jhep.2008.05.004
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：157 / 159
页数：3
相关论文
共 50 条
  • [21] Safety of peginterferon alfa-2a plus ribavirin in a large multinational cohort of chronic hepatitis C patients
    Lee, Samuel S.
    Roberts, Stuart K.
    Berak, Hanna
    Dusheiko, Geoffrey M.
    Harley, Hugh A.
    Gane, Edward J.
    Husa, Petr
    Horsmans, Yves J.
    Hadziyannis, Stephanos J.
    Heathcote, E. Jenny
    Messinger, Diethelm
    Tatsch, Fernando
    Han, Kwang-Hyub
    Ferenci, Peter
    [J]. LIVER INTERNATIONAL, 2012, 32 (08) : 1270 - 1277
  • [22] Peginterferon alfa-2a (Pegasys) for chronic hepatitis C
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2003, 45 (1151): : 19 - 20
  • [23] Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons
    Chung, RT
    Andersen, J
    Volberding, P
    Robbins, GK
    Liu, T
    Sherman, KE
    Peters, MG
    Koziel, MJ
    Bhan, AK
    Alston, B
    Colquhoun, D
    Nevin, T
    Harb, G
    van der Horst, C
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 451 - 459
  • [24] Treatment persistence in and cost of therapy for patients with chronic hepatitis C: Peginterferon alfa-2a plus ribavirin versus peginterferon alfa-2b plus ribavirin
    Brixner, Diana I.
    Ye, Xin
    Chu, Teng-Chiao
    Blumentals, William A.
    Hassanein, Tarek I.
    [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2009, 66 (24) : 2171 - 2178
  • [25] Antiviral activity of telaprevir (VX-950) and peginterferon alfa-2a in patients with hepatitis C
    Forestier, Nicole
    Reesink, Hendrik W.
    Weegink, Christine J.
    McNair, Lindsay
    Kieffer, Tara L.
    Chu, Hui-May
    Purdy, Susan
    Jansen, Peter L. M.
    Zeuzem, Stefan
    [J]. HEPATOLOGY, 2007, 46 (03) : 640 - 648
  • [26] Pharmacoeconomic analysis of the treatment of chronic hepatitis C with peginterferon alfa-2a or peginterferon alfa-2b plus ribavirin in Spain
    Turnes, Juan
    Romero-Gomez, Manuel
    Planas, Ramon
    Sola, Ricard
    Garcia-Samaniego, Javier
    Diago, Moises
    Crespo, Javier
    Calleja, Jose Luis
    Rubio-Terres, Carlos
    Ventayol, Pere
    [J]. GASTROENTEROLOGIA Y HEPATOLOGIA, 2013, 36 (09): : 555 - 564
  • [27] Efficacy and Safety of Peginterferon Alfa-2a and Ribavirin Treatment of Chronic Hepatitis C in the Republic of Serbia
    Bozic, Milena
    Bojovic, Ksenija
    Fabri, Milotka
    Nozic, Darko
    Trkulja, Bojan
    Milosevic, Ivana
    [J]. SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2012, 140 (7-8) : 448 - 455
  • [28] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in children and adolescents
    Sokal, Etienne M.
    Bourgois, Annick
    Stephenne, Xavier
    Silveira, Themis
    Porta, Gilda
    Gardovska, Dace
    Fischler, Bjorn
    Kelly, Deirdre
    [J]. JOURNAL OF HEPATOLOGY, 2010, 52 (06) : 827 - 831
  • [29] Age-related differences in response to peginterferon alfa-2a/ribavirin in patients with chronic hepatitis C infection
    Roeder, Claudia
    Jordan, Sabine
    zur Wiesch, Julian Schulze
    Pfeiffer-Vornkahl, Heike
    Hueppe, Dietrich
    Mauss, Stefan
    Zehnter, Elmar
    Stoll, Sabine
    Alshuth, Ulrich
    Lohse, Ansgar W.
    Lueth, Stefan
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (31) : 10984 - 10993
  • [30] Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients
    Torriani, FJ
    Rodriguez-Torres, M
    Rockstroh, JK
    Lissen, E
    Gonzalez-García, J
    Lazzarin, A
    Carosi, G
    Sasadeusz, J
    Katlama, C
    Montaner, J
    Sette, HJ
    Passe, S
    De Pamphilis, J
    Duff, F
    Schrenk, UM
    Dieterich, DT
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05): : 438 - 450
12345